Filtration leader Lydall has sold Charter Medical to a subsidiary of Fenner PLC for $29.9 million.
Charter is a designer and manufacturer of speciality single-use products employed in blood management, blood filtration and biopharmaceutical applications for the collection, processing, and storage of biological fluids
Already have an account? Log In
Recommended
Most Popular
Latest Magazine
Features
Nonwovens News talks to Murat Dogru about the upcoming OUTLOOK conference
New line concepts and digital tools are helping nonwovens producers boost output, cut waste and ease labour pressures
New research is exploring the benefits of using PCM impregnated nonwovens for use in composite reinforcements for the construction sector
News
Lenzing to prioritise nonwovens as fibre business reshaped
Turkish yarn manufacturer to enter nonwovens market
Shaping the future of filtration at Filtrex
Other publications from MCL News & Media
